BRIEF-Eyegate says is eligible to get additional milestone payment from Valeant for EGP-437
Sept 12 (Reuters) - Eyegate Receives Additional Milestone Payment From Valeant Pharmaceuticals For Egp
* Granted valeant exclusive commercial and manufacturing rights to company's eyegate ii delivery system, EGP-437 combination product
* Company is eligible to receive milestone payments totaling up to $32.5 million Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.